Aktie SAKAR SAKAR HEALTHCARE LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sakar Healthcare Limited

Aktien

SAKAR

INE732S01012

SAKAR

Verzögert NSE India S.E.
Andere Börsenplätze
 12:10:24 16.07.2024 		% 5 Tage % 1. Jan.
333.6 INR 0.00% Intraday Chart für Sakar Healthcare Limited -1.45% -16.60%
21.05. Sakar Healthcare Limited meldet die Ergebnisse für das vierte Quartal und das Gesamtjahr bis zum 31. März 2024 CI
06.03. Sakar Healthcare Ltd. erhält EU-GMP-Zulassung mit Datum vom 5. März 2024 und einer Gültigkeit von drei Jahren ab dem geprüften Datum CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Sakar Healthcare Ltd Receives EU GMP Approval Dated 5th March 2024With A Validity of Three Years from Audited Date
Sakar Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Sakar Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Sakar Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Sakar Healthcare Limited announced that it expects to receive INR 599.999123 million in funding from Tata Investment Corporation Limited
Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Sakar Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Sakar Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Indian shares seen opening lower; U.S. jobs data in focus
Sakar Healthcare : Appointment
Sakar Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Sakar Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022
Sakar Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Sakar Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Sakar Healthcare's Fully-Integrated Anti-Cancer Formulation Unit, Now Starting with Research Laboratories
Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
Sakar Healthcare Limited announced that it has received INR 148.5 million in funding from HBM Partners Ltd.
Sakar Healthcare Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SAKAR Aktie
  4. Nachrichten Sakar Healthcare Limited
  5. Andere Sprachen